quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:30:00·14d
PRRelease
Amazon.com Inc. logo
Johnson & Johnson logo
NVIDIA Corporation logo
+1

Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value

AMZN· Amazon.com Inc.JNJ· Johnson & JohnsonNVDA· NVIDIA CorporationTSLA· Tesla Inc.
Consumer DiscretionaryHealth CareTechnology
Original source

Companies

  • AMZN
    Amazon.com Inc.
    Consumer Discretionary
  • JNJ
    Johnson & Johnson
    Health Care
  • NVDA
    NVIDIA Corporation
    Technology
  • TSLA
    Tesla Inc.
    Industrials

Recent analyst ratings

  • Apr 20AMZNUpdateKeyBanc Capital Markets$325.00
  • Apr 20TSLAUpdateJefferies$350.00
  • Apr 17AMZNUpdateTruist$285.00
  • Apr 14TSLAUpdateUBS$352.00
  • Apr 13TSLAUpdateRBC Capital Mkts$480.00
  • Apr 8JNJUpdateTD Cowen$250.00

Related

  • INSIDER6h
    CEO Musk Elon returned 96,000,000 shares to the company, decreasing direct ownership by 18% to 423,743,904 units (SEC Form 4)
  • PR13h
    Energy Constraints Emerging as Critical Factor in Sustaining AI Expansion
  • SEC1d
    SEC Form 10-Q filed by Tesla Inc.
  • SEC1d
    Tesla Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR1d
    Tesla Releases First Quarter 2026 Financial Results
  • SEC1d
    SEC Form 10-Q filed by Johnson & Johnson
  • PR1d
    IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)
  • INSIDER2d
    SEC Form 4 filed by Jassy Andrew R
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022